Navigation Links
MedAvante Honored By Ernst & Young LLP and Red Herring
Date:7/3/2012

HAMILTON, N.J., July 3, 2012 /PRNewswire/ -- MedAvante, Inc., the world's leading provider of centralized assessments in clinical trials of treatments for central nervous system (CNS) disorders, has been honored for excellence and innovation by two major recognition programs.  

MedAvante co-founder and Chief Executive Officer Paul M. Gilbert  was selected by an independent panel of judges to receive the Ernst & Young Entrepreneur Of The Year® 2012 Award in the Life Science category at a gala event in New Brunswick, NJ.  One of the world's most prestigious business awards for entrepreneurs, the Ernst & Young competition recognizes excellence and extraordinary success as well as personal commitment to business and community.

A second honor came from global media company Red Herring, whose editorial team named MedAvante to the Red Herring Top 100 Americas list of innovative, unique and promising startup companies in North America.  Gilbert and co-founder Amy Ellis, MedAvante Chief Strategy and Marketing Officer, were recognized at the Red Herring 2012 Top 100 Americas forum in San Diego, CA.

"MedAvante is very proud to see our achievements over the past decade and our potential for the future acknowledged in such impressive competitions," said Gilbert.  "These honors represent further evidence that our solutions are finding increasing acceptance worldwide among sponsors of clinical trials in the CNS field," he said.

To solve the intractable problem of mental health trials that fail to reach conclusive results, MedAvante connects its blinded, independent clinicians with research trial sites, either to directly interview study subjects live via video conferencing, or to monitor and evaluate recordings of assessments conducted at these sites.

Standardization through MedAvante's centralized trial services prevents clinical bias and minimizes variability, two root causes of inconclusive studies.  As a result, drug developers can achieve increased study power and reduce the risk of a failed trial.

"Because we've demonstrated that we're able to solve the intractable problem of failed CNS trials, we are expanding rapidly, both geographically, from the U.S., Russia and Eastern and Western Europe into Latin America and Asia Pacific regions, and by entering new therapeutic areas such as neurocognition with work on global Alzheimer's disease studies," said Gilbert.

Gilbert will now be eligible for consideration for the Ernst & Young National Entrepreneur Of The Year 2012 Award, and MedAvante will be a candidate for the 2012 Red Herring Global Top 100 honor.

About MedAvante, Inc.

MedAvante is the leading global provider of centralized expert psychiatric and neurocognition rating and monitoring services to the pharmaceutical, biotechnology and medical device industries.  MedAvante solutions help sponsors achieve enhanced assay sensitivity for increased drug effect and reduced trial failure rates, enabling them to bring better drugs to market faster. With headquarters in Hamilton NJ and operations hubs in Moscow and Munich, MedAvante delivers central trial services in more than 20 countries worldwide from within each country.  For more information, please visit www.medavante.com


'/>"/>
SOURCE MedAvante, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardinal Health Honored With Best Employers for Healthy Lifestyles Award by National Business Group on Health
2. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
3. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Honored Dr. Thomas Fogarty with the 2012 Lifetime Achievement Award
4. Upsher-Smith Is Honored with Prestigious Industry Award for Excellence and Innovation
5. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
6. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
7. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
8. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
9. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
10. Masimo CEO Joe Kiani Named Ernst & Young Entrepreneur of the Year
11. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017 /PRNewswire/ ... results of collaboration started in 2016, in which ... "Artificial Brain SOINN". The companies achieved initial results ... ultrasound solution by Artificial Brain SOINN. The results ... Tokyo Big Sight, April 19-21, at booths 4505 ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 and ... educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd said, ... patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to using ... Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 years, ... USA, and former member of the American Association of Christian Counselors. Rachel studied ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/22/2017)... (PRWEB) , ... April 22, ... ... Administration of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its ... Heron-Doerr, PROSHRED® Philadelphia specializes in providing information destruction , recycling, ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
Breaking Medicine News(10 mins):